SCHEMBL1089112

SCHEMBL1089112

c1ccc(CNc2nc(N3CCc4ccccc4C3)c3ccccc3n2)nc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 1/20 0.51
SUMO3 P55854 1/20 0.49
SUMO2 P61956 1/20 0.49
SUMO1 P63165 1/20 0.49
ADORA2A P29274 2/20 0.47
ADORA1 P30542 1/20 0.47
BCHE P06276 1/20 0.46
ACHE P22303 1/20 0.46
GRIN2D O15399 4/20 0.45
GRIN3B O60391 4/20 0.45
GRIN1 Q05586 4/20 0.45
GRIN2A Q12879 4/20 0.45
GRIN2B Q13224 4/20 0.45
GRIN2C Q14957 4/20 0.45
GRIN3A Q8TCU5 4/20 0.45
KDM4E B2RXH2 3/20 0.45
HTT P42858 2/20 0.45
PDE5A O76074 2/20 0.44
LMNA P02545 1/20 0.44
TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1091263 0.91 GBA1 (0.48) GBA1SUMO3SUMO2SUMO1ACHE
SCHEMBL1090896 0.85 GBA1 (0.53) GBA1BCHEACHEGRIN2DGRIN3B
SCHEMBL1090973 0.84 GBA1 (0.48) GBA1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL1091107 0.84 ADORA2A (0.64) SUMO3SUMO2SUMO1ADORA2AADORA1
SCHEMBL1091049 0.83 ADORA2A (0.66) SUMO3SUMO2SUMO1ADORA2AADORA1
SCHEMBL1091029 0.83 ADORA2A (0.66) SUMO3SUMO2SUMO1ADORA2AADORA1
SCHEMBL1089924 0.83 ADORA2A (0.66) SUMO3SUMO2SUMO1ADORA2AADORA1
SCHEMBL1091100 0.81 SUMO3 (0.54) GBA1SUMO3SUMO2SUMO1ADORA2A
SCHEMBL1090653 0.80 MRGPRX1 (0.61) GBA1BCHEACHEGRIN2DGRIN3B
SCHEMBL1090535 0.80 HRH4 (0.51) GBA1GRIN2DGRIN3BGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 US disclosed
EP-1571146-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-09-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 GBA1 3584/4885SUMO3 2877/4885SUMO2 4013/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 GBA1 3584/4885SUMO3 2877/4885SUMO2 4013/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 GBA1 3584/4885SUMO3 2877/4885SUMO2 4013/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.